Cheng-Chi Lee

Title: Cheng-Chi Lee: Innovator in Genetic Screening

Introduction

Cheng-Chi Lee is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of genetic screening, particularly in the diagnosis of diseases caused by trinucleotide repeat sequence instability. With a total of 5 patents to his name, Lee's work is paving the way for advancements in medical diagnostics.

Latest Patents

One of Cheng-Chi Lee's latest patents focuses on large-scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6. This invention provides a method for screening individuals at risk for developing diseases linked to trinucleotide repeat sequence instability. Specifically, it targets individuals at risk for autosomal dominant spinocerebellar ataxia type 6 by determining the length of a CAG trinucleotide repeat in the α-calcium channel gene of the individual. Additionally, the patent outlines a method for identifying genes that are disease-causing due to trinucleotide repeat sequence instability through large-scale genotyping.

Career Highlights

Cheng-Chi Lee is associated with the Research Development Foundation, where he continues to innovate and contribute to the field of genetic research. His work has garnered attention for its potential impact on understanding and diagnosing genetic disorders.

Collaborations

Lee collaborates with notable colleagues, including Urs Albrecht and Gregor Eichele, who share his commitment to advancing genetic research and diagnostics.

Conclusion

Cheng-Chi Lee's contributions to genetic screening and diagnostics are invaluable. His innovative patents and collaborative efforts are helping to shape the future of medical research and improve patient outcomes.